MENLO PARK, Calif., August 12, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter ended June 30, 2021.
Recent Business Highlights
• Generated second quarter 2021 total revenue of $12.5 million, an increase of 258% compared to the prior year period, including;
• Surgical Glaucoma sales of $12.0 million, an increase of 263% compared to the prior year period
• Dry Eye sales of $0.5 million, an increase of 169% compared to the prior year period
• Expanded gross margin to 82% in the second quarter 2021 versus 40% in the prior year period
• Completed an initial public offering in July raising approximately $253 million of net proceeds after deducting underwriting discounts and…